Iris International announced a third purchasing agreement to sell urine analyzers to the Department of Veteran Affairs, sending its stock price to a 52-week high. Early in the day, shares trading on the Nasdaq hit a high of $20.85, up from a low of $7.25 last October. The deal announced is a five-year purchasing agreement with the Veterans Integrated Services Network’s VISN 16 region, which covers locations in Oklahoma, Arkansas, Louisiana, Mississippi, Missouri, Alabama, Florida and parts of Texas. The order includes a total of 23 analyzers. The company has previously sold machines to VISNs in cover the Northeast and parts of the Midwest.
